Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Koninklijke Philips (PHG) Work In Process (2016 - 2023)

Koninklijke Philips has reported Work In Process over the past 8 years, most recently at $593.9 million for Q4 2023.

  • Quarterly results put Work In Process at $593.9 million for Q4 2023, down 10.16% from a year ago — trailing twelve months through Dec 2023 was $593.9 million (down 10.16% YoY), and the annual figure for FY2023 was $593.9 million, down 10.16%.
  • Work In Process for Q4 2023 was $593.9 million at Koninklijke Philips, down from $661.1 million in the prior quarter.
  • Over the last five years, Work In Process for PHG hit a ceiling of $739.0 million in Q4 2021 and a floor of $446.1 million in Q4 2019.
  • Median Work In Process over the past 5 years was $640.3 million (2020), compared with a mean of $616.1 million.
  • Biggest five-year swings in Work In Process: surged 43.53% in 2020 and later dropped 10.54% in 2022.
  • Koninklijke Philips' Work In Process stood at $446.1 million in 2019, then skyrocketed by 43.53% to $640.3 million in 2020, then rose by 15.42% to $739.0 million in 2021, then dropped by 10.54% to $661.1 million in 2022, then fell by 10.16% to $593.9 million in 2023.
  • The last three reported values for Work In Process were $593.9 million (Q4 2023), $661.1 million (Q4 2022), and $739.0 million (Q4 2021) per Business Quant data.